Document is current
Any future updates will be listed below
-
Authors
Sadeghi, Elham
Gandhi, Priyanka
Davis, Elli
Singh, Sumit Randhir
Ibrahim, Mohammed Nasar
Bollepalli, Sandeep Chandra https://orcid.org/0000-0002-9971-9335
Vupparaboina, Kiran Kumar
Sahel, Jose Alain https://orcid.org/0000-0002-4831-1153
Eller, Andrew W. https://orcid.org/0000-0002-6472-5460
Chhablani, Jay https://orcid.org/0000-0003-1772-3558
- License Information
-
More Information
Article History
Received: 25 July 2025
Revised: 3 December 2025
Accepted: 2 February 2026
First Online: 10 February 2026
Competing interests
: JAS: Co-founder of NetraMind Innovations; Pixium Vision, GenSight Biologics, Sparing Vision, Prophesee, and Chronolife. Dr Chhablani: Co-founder of NetraMind Innovations; Consultant: Allergan; Novartis; Salutaris; OD-OS; Erasca; B&L, Iveric Bio; Equity: Ocular Therapeutics, AcuViz, AbbVie; Royalty: Springer; Elsevier. No conflicting relationship exists for any author. Dr Vupparaboina: Co-founder of NetraMind Innovations. Dr Bollepalli: Co-founder of NetraMind Innovations.
: The study adhered to the tenets of the Declaration of Helsinki. Informed consent was obtained from all the patients included in the study. Ethical clearance was obtained by the institutional review board of the University of Pittsburgh. IRB: STUDY21060214
